Neudle.com: lipid lowering agent

Differential
(Click to cross reference)

ABCS

acetylcholine receptor antibody

acoustic neurinoma, bilateral

acquired immunodeficiency syndrome

addiction, heroin

adrenoleukodystrophy

adrenomyeloneuropathy

advances in neurology

adverse drug reaction

alcohol

Alzheimer's disease

Alzheimer's disease, treating associated medical problems in

Alzheimer's disease, treatment of

amphotericin B

amyloid angiopathy, cerebral

amyloid beta protein

angiotensin-converting enzyme, inhibitors

anterior tibial muscle weakness

anti HMGCR antibody

anticoagulant, complications of

anticoagulant, contraindications

anticoagulant, discontinuation

anticoagulant, treatment

anticoagulant, treatment in CVD

anticonvulsants

anticonvulsants, blood level determination of

aspartate aminotransferase

aspirin

asymptomatic

atherosclerosis, generalized

atorvastatin

atrial fibrillation

attention deficit disorder with hyperactivity

blood pressure, control

blood pressure, lowering

brain atrophy

brain natriuretic peptide

calcium antagonist

carbenoxolone

cardiomyopathy

cardiovascular disease

carotid artery

carotid artery atherosclerosis

carotid artery atherosclerosis, pathogenesis

carotid artery atherosclerosis, regression

carotid artery disease

carotid artery disease, asymptomatic

carotid artery disease, medical management

carotid artery disease, noninvasive evaluation of

carotid artery intima-media thickness

carotid artery plaque

carotid artery stenosis

carotid artery stenosis, intracranial

carotid artery stenosis, risk of stroke with

carotid artery stenosis, surgical treatment

carotid artery stenosis, symptomatic

CD4 counts

cerebral atherosclerosis

cerebral infarction

cerebral infarction, hemorrhagic

cerebral ischemia

cerebrovascular accident

cerebrovascular accident, acute management of

cerebrovascular accident, classification

cerebrovascular accident, model for predicting risk of

cerebrovascular accident, pathophysiology

cerebrovascular accident, prevention of

cerebrovascular accident, primary prevention

cerebrovascular accident, prognosis in

cerebrovascular accident, racial differences

cerebrovascular accident, recurrent

cerebrovascular accident, secondary prevention

cerebrovascular accident, severity

cerebrovascular accident, sex distribution

cerebrovascular accident, volume

cerebrovascular accident, women

cerebrovascular accident, work up for

cerebrovascular disease

cerebrovascular disease, risk factors in

cerebrovascular disease, treatment of

Clinical Pathologic Conference(C.P.C.)

controversies in neurology

coronary artery disease

corpus callosum, lesion of

cost effectiveness

coumarin

creatine kinase

creatine phosphokinase(CPK)elevated

decision analysis

dementia

dementia, prevention of

dementia, treatment of

developmental disability

diabetes mellitus

diarrhea

diet

difficulty going down stairs

dipyridamole

disability, neurological

distal muscle weakness

diuretic

drug abuse

drug induced neurologic disorders

electrocardiogram, abnormal

electromyogram

embolism, platelet

endarterectomy, carotid

endarterectomy, carotid-complications of

endarterectomy, carotid-indications for

endarterectomy, carotid-long term results

endarterectomy, carotid-morbidity and mortality with

endarterectomy, carotid-timing after stroke

endovascular therapy

enzyme inhibition

enzyme, induction

enzyme, muscle disease

eosinophilia

eosinophilic fasciitis

epidemiology of neurology

epsilon-aminocaproic acid(E.A.C.A.)

evidence-based research

glucose tolerance test, abnormal

headache

hemosiderosis of CNS, superficial

high arched feet

hip flexor weakness

histopathology

HMGcoA reductase inhibitors

homocysteine, serum

hospitalization

human diploid cell rabies vaccine

human immunodeficiency virus type 1

iatrogenic neurologic disorders

imbalance

immunomodulation

immunosuppressive agents

indinavir

intellectual deficit

intelligence quotient

interferon

interferon beta 1-a

intracerebral hemorrhage

intracerebral hemorrhage, lobar

intracerebral hemorrhage, recurrent

ipecac

Krabbe's disease

leg weakness, bilateral

liver function enzymes

lovastatin

lysosomal storage disease

medication withdrawal

microangiopathy, brain

microhemorrhage, intracerebral

middle cerebral artery atherosclerosis

Mini Mental Status Examination

MRI, contrast enhanced

MRI, mismatch between perfusion/diffusion

MRI, muscle

multiple sclerosis

multiple sclerosis, relapsing

multiple sclerosis, treatment of

multiple sclerosis, worsening

muscle biopsy

muscle cramp

muscle pain

muscle strength, testing

muscle swelling

muscle tenderness

muscle weakness

muscle weakness, causes of

muscle weakness, proximal

myasthenia gravis

myasthenia gravis, exacerbation

myasthenic syndrome

myocardial infarction

myopathy, drug-induced

myopathy, hypokalemic

myopathy, necrotizing

myopathy, necrotizing, autoimmune

myopathy, necrotizing, immune-mediated

myopathy, proximal

myopathy, steroid induced

myopathy, steroid responsive

neoplasm, primary of CNS-intraventricular

neurofibromatosis 1

neuroleptic

neurologic disease, diagnoses of

neuropathology

neuropathy

neuropathy, demyelinating

neuropathy, iatrogenic

neuropathy, medication induced

neuropathy, peripheral

neuropathy, toxic

neuroprotective agents

NIH stroke scale

nonsteroidal anti-inflammatory drug

old age, neurology of

Parkinson disease, drug induced

Parkinson disease, unmasked

parvovirus

patient information and support

perhexiline maleate

pes cavus

physical activity

platelet inhibiting drugs

platelet inhibiting drugs, combined

platelet inhibiting drugs, contraindications

prevention of neurologic disorders

prognosis

progressive neurologic disorder

protease inhibitor, HIV-1

psychological testing

reversible neurologic disorder

review article

rhabdomyolysis

rifampin

risk factor calculator

risk factors

risk factors, modification

risk-benefit assessment

selective serotonin reuptake inhibitors

serum alanine aminotransferase

sex reassignment surgery

statin therapy, discontinuation

statin therapy, dose

stent, carotid artery

the million hearts initiative

toe walking

transgender

transient ischemic attack

transient ischemic attack, evaluation

transient ischemic attack, recurrent

transient ischemic attack, treatment of

transient neurologic deficit

transluminal angioplasty, intracranial

treatment of neurologic disorder

ultrasonography, carotid artery

urine, dark

vertebral-basilar artery, atherosclerosis

vincristine neurotoxicity

viral infection

viral load

vitamin supplementation

walking, delayed

walking, difficulty with

weakness

weakness, generalized

weakness, progressive

Showing articles 100 to 150 of 3629 << Previous Next >>

Influence of Cholesterol on Survival After Stroke:Retrospective Study
BMJ 314:1584-1588, Dyker,A.G.,et al, 1997

Reduction in Carotid Arterial Wall Thickness Using Lovastatin & Dietary Therapy
Ann Int Med 124:548-556, Hodis,H.N.,et al, 1996

Pravastatin Reduces Carotid Intima-Media Thickness Prog in an Asympt Hypercholesterolemic Pop, CAIUS Study
Am J Med 101:627-634, Mercuri,M.,et al, 1996

Parkinsonism Unmasked by Lovastatin
Ann Neurol 37:685-686, Muller,T.,et al, 1995

Peripheral Neuropathy with Bezafibrate
BMJ 309:929, Ellis,C.J.,et al, 1994

HMG-CoA Reductase Inhibitor Therapy and Peripheral Neuropathy
Ann Int Med 120:970, Jacobs,M.B., 1994

One-Year Reduction and Longitudinal Analysis of Carotid Intima-Media Thickness Associated with Colestipol/Niacin Therapy
Stroke 24:1779-1783, Mack,W.J.,et al, 1993

Gemfibrozil-Induced Myopathy
Arch Int Med 151:1873-1874, Magarian,G.J.,et al, 1991

Cholesterol-Lowering Agent Myopathy (CLAM)
Neurol 41:1159-1160, London,S.F.,et al, 1991

Myopathy and Rhabdomyolysis Associated with Lovastatin-Gemfibrozil Combination Therapy
JAMA 264:71-75, Pierce,L.R.,et al, 1990

Atherosclerosis:Current Concepts on Pathogenesis and Interventional Therapies
Ann Neurol 26:3-12, Yatsu,F.M.&Fisher,M., 1989

Drug-Induced Myopathies In Man
Lancet 2:562-566, Lane,R.J.M.,et al, 1978

Clofibrate-Induced Muscle Damage with Myoglobinuria & Cardiomyopathy
NEJM 296:942, Smals,A.G.H., 1977

Platelet-Inhibiting Drugs in the Prevention of Clinical Thrombotic Disease
NEJM 293:174, Genton,E.,et al, 1975

The Treatment of Cerebrovascular Disease with Clofibrate
VA Cooperative Study Group, Stroke 4:6841973., , 1973

Muscular Syndrome after Clofibrate
NEJM 286:1110, Katsilambros,N., 1972

Clofibrate for the Treatment of Occlusive CVD-Correspondence
NEJM 287:671, Hirsch,S.,et al, 1972

A 41-Year-Old Man with Steroid-Responsive Hemiparesis
Neurol 106:e214088, Obaidi,Z.A.,et al, 2026

Progressive Quadriparesis and Falls in a 66-Year-Old Man With Longstanding Human Immunodeficiency Virus
Neurol 106:e214621, Ong,B.A. & Carlson,A.K., 2026

Intravenous Thrombolysis Use in the Late Time Window Before Interhospital Transfer for Thrombectomy
JAMA Neurol 83:60-67, Seners,P.,et al, 2026

Intravenous Thrombolysis Use Before Inter-Facility Transfer for Thrombectomy:Association with Efficacy and Safety Outcomes
Ann Neurol 98:871-880, Seners,P.,et al, 2025

Effectiveness and Safety of IV Thrombolysis Before Hospital Transfer for Thrombectomy in Patients With Basilar Artery Occlusion
Neurol 105:e214355, Liebart,S.,et al, 2025

Upbeat Nystagmus From Dorsolateral Pontine Hemorrhagic Transformation
Neurol 106:e214467, Chen,H. & Li, J., 2025

Chasing the New Dragon, Toxic Spongiform Leukoencephalopathy with Chronic Fentanyl Inhalation
Neurol 106:e214517, Maisenbacher,M. & Jayagopal, L.A., 2025

Efficacy and Safety of IV Thrombolysis for Acute Ischemic Stroke Patients with Moyamoya Disease
Neurol 104:e210243, Chen,H.,et al, 2025

Amyloid-Related Imaging Abnormalities (ARIA) in Clinical Trials of Gantenerumab in Early Alzheimer Disease
JAMA Neurol 92:19-29, Salloway,S.,et al, 2025

Clinicopathologic Conference, Posterior Reversible Encephalopathy Syndrome Due to Sickle Cell Disease
NEJM 392:268-276, Case 2-2025, 2025

Black Turbinate Sign as an Early Clue of Rhino-Orbital-Cerebral Mucormycosis
Neurol 104:e210202, Xie,J.S.,et al, 2025

Dextromethorphan-Associated Neurotoxicity with Cerebellar Edema Syndrome in Young Children:Neuroimaging Features
AJNR 46:390-394, Sharma,S.,et al, 2025

Clinical Presentation, Investigation Findings, and Outcomes of IgG4-Related Pachymeningitis,A Systematic Review
JAMA Neurol 82:193-199, Terrim,S.,et al, 2025

Methamphetamine-Induced Basal Ganglia Toxicity Presenting as Parkinsonism
Neurol 104:e213365, Yi,M.Y.,et al, 2025

Endovascular Thrombectomy for Extracranial Internal Carotid Artery Occlusions with Large Ischemic Strokes
Neurol 104:e210269, Ortega-Gutierrez,S.,et al, 2025

Endovascular Therapy for Patients with Low NIHSS Scores and Large Vessel Occlusion in the 6- to 24-Hour Window
Neurol 104:e213442, Marto,J.P.,et al, 2025

Inebilizumab for Treatment of IgG4-Related Disease
NEJM 392:1168-1177, Stone,J.H.,et al, 2025

Beyond Glucocorticoids for IgG4-Related Disease
NEJM 392:1232-1233, Spiera,R., 2025

Alteplase for Posterior Circulation Ischemic Stropke at 4.5 to 24 Hours
NEJM 392:1288-1296, Yan,S.,et al, 2025

"Innumerable" lesion burden on brain MRI - a diagnostic approach
Diagnosis doi.org/10.1515/dx- 2025-2029, Finelli,P.F., 2025

Endovascular Treatment of Stroke Due to Medium-Vessel Occlusion
NEJM 392:1385-1395,1440, Goyal,lM.,et al, 2025

Endovascular Treatment for Stroke Due to Occlusion of Medium or Distal Vessels
NEJM 392:1374-1384,1440, Psychogios,M.,et al, 2025

Chronic Neuropsychiatric Sequelae Associated with Kambo Intoxication
JAMA Neurol 82:418-419, Jauregui,R.,et al, 2025

Endovascular Thrombectomy for Large Ischemic Core Stroke, A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Neurol 104:e213443, Liu,C.,et al, 2025

Long-Term Effects of Antidarsagene Autotemcel for Metachromatic Leukodystrophy
NEJM 392:1609-1620, Fumagalli,F.,et al, 2025

A 69-Year-Old Woman with Ophthalmoplegia
Neurol 104:e213763, Yu, H & Frey, J, 2025

Risk of Dementia in Individuals with Emergency Department Visits or Hospitalizations Due to Cannabis
JAMA Neurol 82:570-579, Myran,D.T.,et al, 2025

A Phase 3 Trial of Inebilizumab in Generalized Myasthenia Gravis
NEJM 392:2309-2320, Nowak,R.J.,et al, 2025

Myasthenia Gravis - Redemption for B-Cell Depletion
NEJM 392:2382-2384, Wolfe,G.I. & Shelly,S., 2025

Efficacy and Safety of Ofatumumab Treatment for Anti-NMDA Receptor Autoimmune Encephalitis (OFF-AE): A Prospective, Multicenter Cohort Study
Ann Neurol 98:80-92, Guo,K.,et al, 2025

Disease-Modifying, Neuroprotective Effect of N-Acetyl-L-Leucine in Adult and Pediatric Patients with Neimann-Pick Disease Type C
Neurol 105:e213589, Patterson,M.C., et al, 2025

Intravenous Tenecteplase before Thrombectomy in Stroke
NEJM 393:139-150, Qiu,Z.,et al, 2025

Intra-Arterial Thrombolysis Following Endovascular Recanalization for Large Vessel Occlusion Stroke
Neurol 105: e213842, Jiang,X.,et al, 2025

Showing articles 100 to 150 of 3629 << Previous Next >>